
|Articles|January 1, 2004
- Pharmaceutical Executive-01-01-2004
Table of Contents
Table of Contents
Advertisement
Articles in this issue
about 22 years ago
PE's Annual Sales and Marketing Employment Survey: The Big Squeezeabout 22 years ago
Streamlining For Success with Fred Price of BioMarinabout 22 years ago
The Making of a New DiseaseNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Generates $1.5 Billion Stockpile of Orforglipron Ahead of FDA Decision
2
Pharmaceutical Executive Daily: Eli Lilly's $1.5 Billion Stockpile of Orforglipron
3
Pharm Exec's 2026 Pipeline Report: Next Frontiers in Focus
4
Bridging the Data Gap: How Digital Behavioral Insights Can Transform HCP Targeting in Specialty Care
5




